Literature DB >> 10885674

Development of early melanocytic lesions in transgenic mice predisposed to melanoma.

H Zhu1, K Reuhl, R Botha, K Ryan, J Wei, S Chen.   

Abstract

We have previously described a line of transgenic mice (TG3) that spontaneously develops heritable malignant melanoma. Histological analysis of these animals during the first postnatal month is described here. In the TG3 line, the number of melanocytes is increased at all anatomical sites to which neural-crest-derived melanocytes normally migrate. Clonal expansion and morphological changes of these melanocytes can be detected as early as postnatal day (PND) 15. By PND 30, cells morphologically indistinguishable from the tumor cells of adult transgenic mice were detected in the ear, eye lid and perianal region. These cells are believed to be the precursors of the primary tumors in adult mice. The stepwise development of melanoma in the TG3 line is similar to the stepwise development of melanoma in humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10885674     DOI: 10.1034/j.1600-0749.2000.130307.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  9 in total

1.  Concurrent Targeting of Glutaminolysis and Metabotropic Glutamate Receptor 1 (GRM1) Reduces Glutamate Bioavailability in GRM1+ Melanoma.

Authors:  Raj Shah; Simar J Singh; Fabian V Filipp; Suzie Chen; Kevinn Eddy
Journal:  Cancer Res       Date:  2019-04-15       Impact factor: 12.701

2.  Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice.

Authors:  Kyu Yeong Choi; Kai Chang; James M Pickel; John D Badger; Katherine W Roche
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-06       Impact factor: 11.205

Review 3.  Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development.

Authors:  Yarí E Marín; Suzie Chen
Journal:  J Mol Med (Berl)       Date:  2004-08-21       Impact factor: 4.599

Review 4.  Metabotropic glutamate receptors (mGlus) and cellular transformation.

Authors:  Seung-Shick Shin; Jeffrey J Martino; Suzie Chen
Journal:  Neuropharmacology       Date:  2008-05-07       Impact factor: 5.250

5.  Functional effects of GRM1 suppression in human melanoma cells.

Authors:  Janet Wangari-Talbot; Brian A Wall; James S Goydos; Suzie Chen
Journal:  Mol Cancer Res       Date:  2012-07-13       Impact factor: 5.852

6.  Role of the G Protein-Coupled Receptor, mGlu1, in Melanoma Development.

Authors:  Janet Wangari-Talbot; James Goydos; Suzie Chen
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-26

7.  Bioinformatics analysis of microarray data to reveal the pathogenesis of diffuse intrinsic pontine glioma.

Authors:  Li Wei; Fei He; Wen Zhang; Wenhua Chen; Bo Yu
Journal:  Biol Res       Date:  2018-08-20       Impact factor: 5.612

Review 8.  Overcoming Immune Evasion in Melanoma.

Authors:  Kevinn Eddy; Suzie Chen
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

Review 9.  Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.

Authors:  Stacey S Willard; Shahriar Koochekpour
Journal:  Int J Biol Sci       Date:  2013-08-09       Impact factor: 6.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.